Kovai Medical Center and Hospital Statistics
Total Valuation
Kovai Medical Center and Hospital has a market cap or net worth of INR 59.62 billion. The enterprise value is 60.65 billion.
Market Cap | 59.62B |
Enterprise Value | 60.65B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | Aug 1, 2024 |
Share Statistics
Kovai Medical Center and Hospital has 10.94 million shares outstanding. The number of shares has increased by 0.02% in one year.
Shares Outstanding | 10.94M |
Shares Change (YoY) | +0.02% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | 15.82% |
Owned by Institutions (%) | 7.20% |
Float | 4.48M |
Valuation Ratios
The trailing PE ratio is 30.67.
PE Ratio | 30.67 |
Forward PE | n/a |
PS Ratio | 4.73 |
PB Ratio | 6.71 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 31.19 |
EV / Sales | 4.81 |
EV / EBITDA | 16.95 |
EV / EBIT | 22.80 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.35 |
Debt / EBITDA | 0.87 |
Debt / FCF | n/a |
Interest Coverage | 9.20 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 13.69% |
Revenue Per Employee | 2.38M |
Profits Per Employee | 367,831 |
Employee Count | 5,286 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +111.16% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +111.16% |
50-Day Moving Average | 5,319.87 |
200-Day Moving Average | 4,246.33 |
Relative Strength Index (RSI) | 51.17 |
Average Volume (20 Days) | 4,821 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kovai Medical Center and Hospital had revenue of INR 12.60 billion and earned 1.94 billion in profits. Earnings per share was 177.69.
Revenue | 12.60B |
Gross Profit | 6.47B |
Operating Income | 2.66B |
Pretax Income | 2.57B |
Net Income | 1.94B |
EBITDA | 3.54B |
EBIT | 2.66B |
Earnings Per Share (EPS) | 177.69 |
Balance Sheet
The company has 2.08 billion in cash and 3.10 billion in debt, giving a net cash position of -1.03 billion or -93.82 per share.
Cash & Cash Equivalents | 2.08B |
Total Debt | 3.10B |
Net Cash | -1.03B |
Net Cash Per Share | -93.82 |
Equity (Book Value) | 8.89B |
Book Value Per Share | 812.02 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 51.37%, with operating and profit margins of 21.11% and 15.43%.
Gross Margin | 51.37% |
Operating Margin | 21.11% |
Pretax Margin | 20.36% |
Profit Margin | 15.43% |
EBITDA Margin | 28.09% |
EBIT Margin | 21.11% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 10.00, which amounts to a dividend yield of 0.18%.
Dividend Per Share | 10.00 |
Dividend Yield | 0.18% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 2 |
Payout Ratio | n/a |
Buyback Yield | -0.02% |
Shareholder Yield | 0.17% |
Earnings Yield | 3.26% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |